Noble Biomaterials Competitors and Similar CompaniesClear all
Noble Biomaterials's competitors and similar companies include Pelican Expression Technology, Enanta Pharmaceuticals, Bicycle Therapeutics and Walvax Biotechnology.
 Noble Biomaterials Noble Biomaterials is a company that manufactures and supplies antimicrobial products and medical devices. |  Pelican Expression Technology Pelican Expression Technology is a platform of Ligand Pharmaceuticals for recombinant protein production. |  Enanta Pharmaceuticals Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule drugs for virology and immunology. |  Bicycle Therapeutics Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | |
Founding Date | Founding Date 1997 | Founding Date 2009 | Founding Date 1995 | Founding Date 2009 | Founding Date 2001 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Scranton, US HQ | Locations San Diego, US HQ | Locations Watertown, US HQ | Locations Cambridge, GB HQ Cambridge, US | Locations Kunming, CN HQ |
Employees | Employees 1213% increase | Employees 14 | Employees 1459% decrease | Employees 305 | Employees 2,388 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 243.7 m | Valuation ($) 1.7 b | Valuation ($) 3.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $50.3m (FY, 2019) | Revenue (est.) $65.3m (FY, 2025) | Revenue (est.) $72.6m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $4.9m (FY, 2019) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $45.4m (FY, 2019) | Gross profit N/A | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) |
Net income | Net income N/A | Net income $1.1m (FY, 2019) | Net income ($81.9m) (FY, 2025) | Net income ($219m) (FY, 2025) | Net income ¥125.2m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 8m | Total funding raised $ 24m | Total funding raised $ 9.2m | Total funding raised $ 89.4m | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
Pelican Expression Technology
HQ
San Diego, US
Pelican Expression Technology is a platform of Ligand Pharmaceuticals for recombinant protein production.
View companyEnanta Pharmaceuticals
HQ
Watertown, US
Employees
145↓ 9% decrease
Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule drugs for virology and immunology.
View companyBicycle Therapeutics
HQ
Cambridge, GB
Employees
305
Bicycle Therapeutics is a clinical-stage biopharmaceutical company that develops cancer therapies.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company